X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Glucagon-like Peptide-1 (GLP-1) Agonists Companies

This report lists the top Glucagon-like Peptide-1 (GLP-1) Agonists companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Glucagon-like Peptide-1 (GLP-1) Agonists industry.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Agonists Research GLP-1 Agonists Industry Companies

Glucagon-like Peptide-1 (GLP-1) Agonists Top Companies

  1. AstraZeneca

  2. Eli Lilly and Company

  3. Sanofi

  4. Novo Nordisk A/S

  5. Pfizer Inc.

*Disclaimer: Top companies sorted in no particular order

Glucagon-like Peptide-1 (GLP-1) Agonists Market Major Players

Glucagon-like Peptide-1 (GLP-1) Agonists Market Concentration

Glucagon-like Peptide-1 (GLP-1) Agonists Market Concentration

Glucagon-like Peptide-1 (GLP-1) Agonists Company List

                                • Novo Nordisk

                                • Sanofi

                                • Eli Lilly

                                • AstraZeneca

                                • Boehringer Ingelheim

                                • Pfizer

                              • MARKET SHARE ANALYSIS

                                • NovoNordisk

                                • Sanofi

                                • AstraZeneca

                                • Others


                            Specific to Glucagon-like Peptide-1 (GLP-1) Agonists Market
                            Need More Details On Market Players And Competitors?
                            Download Sample

                            GLP-1 Agonists Market Report Snapshots

                            GLP-1 Agonist Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)